It was a great learning indeed! Sad to know a string of #NTDs viz ascariasis/ trichuriasis/dengue fever/ lymphatic filariasis/ cysticercosis, leprosy, echinococcosis, visceral leishmaniasis n rabies continue to afflict #India . Time 2 relook elimination strategies

Thank you Faculty of Medicine Siriraj Hospital, Mahidol U. for all the discussions, your amazing work and being one of our partners of our #dengue alliance. We are so grateful for the opportunity.

Filaria disease head Dr Sabine Specht presents drug development Filarial strategies Drugs for Neglected Diseases initiative JeanMichel Piedagnel ICTMM2020 Bangkok

Fantastic to meet Prof Yongyuth Yuthawong at the opening ceremony of #ICTMM2022

Our 1st Asia science & health journalist workshop kicked off today in Bangkok on the sidelines of #ICTMM2022 . 15 reporters from India, Sri Lanka, Malaysia, Bangladesh & Nepal! We took a quick moment to wish everyone a happy Diwali!

Warm welcome to our foreign media delegation from India, Malaysia, Nepal, Sri Lanka and Bangladesh to #ICTMM2022 . TQ to our partners Drugs for Neglected Diseases initiative for arranging a media workshop in collaboration with our congress.

The Norwegian charity event TV-aksjonen is today! For two hours, up to 100,000 volunteers in every Norwegian city & village will visit households to ask for donations for Leger Uten Grenser & DNDi.

Our Founder Dr Bernard Pécoul with two MSF International doctors: Dr Morten Rostrup and Dr Emmanuel.

Hope Nature and other journals are serious about what they are saying. nature.com/immersive/d428…

Connected with Drugs for Neglected Diseases initiative's Dr Luis Pizarro & Michelle Childs to learn about how they are addressing #GenderEquality in their R&D work

DNDi are already doing fantastic work but we're keen to support them to reach new heights 🏔️

#WHS2022 World Health Summit

.Drugs for Neglected Diseases initiative participating at World Health Summit 2022
co-hosted with World Health Organization (WHO)

#beatNTDs #WHS2022

At World Health Summit 2022:

Executive Director Drugs for Neglected Diseases initiative Dr Luis Pizarro talked about research and development, partnership & access in the context of World Health Organization (WHO) NTD-2030.

#beatNTDs #WHS2022

We are now at a turning point in the history of research & development of #leishmaniasis treatments, writes Dr Fabiana Alves, our NTD Leishmaniasis-Mycetoma Director, in @Medicine_Maker. #HopeForLeishmaniasis WorldLeish7
bit.ly/3RPdIUk

Much needed call for attention for neglected tropical diseases from Federal Chancellor of Germany Bundeskanzler Olaf Scholz at #WHS2022 's opening ceremony!

Mesmerizing...

Director CDRI CSIR-CDRI emphasises on the need to do more upstream research in India and other LMICs

Clinical Infectious Diseases Children – who are the majority of visceral #leishmaniasis patients – also responded well to the treatment.

We are continuing to research even better treatments that would remove the need for injectables and be better adapted to local conditions.   #HopeForLeishmaniasis

'We need to have a much better regulatory system in order to have approvals for new drugs come very quickly in countries. We also need to strengthen local capacities in regulatory & manufacturing.' @drluispizarro on how to use lessons learned from #COVID19 to #beatNTDs . #UNGA77

Results from a study by DNDi & partners show that a better, shorter combination treatment is effective in treating visceral #leishmaniasis in Eastern Africa.

The new treatment is over 91% effective & reduces time in hospital by 18%. #HopeForLeishmaniasis bit.ly/3Rehib3